Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2013
09/26/2013WO2013076316A3 Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)hetarylcarboxamide compounds and their use as herbicides
09/26/2013WO2013032558A3 Products for anti-inflammation support
09/26/2013WO2012085935A3 Diamide piperidine compounds as inhibitors of renin
09/26/2013US20130253201 Process for the preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carbocyclic acids
09/26/2013US20130253188 Novel compounds
09/26/2013US20130253186 Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
09/26/2013US20130253013 Serotonin reuptake inhibitors
09/26/2013US20130253004 Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis
09/26/2013US20130252986 Compounds
09/26/2013US20130252975 Novel rock inhibitors
09/26/2013US20130252974 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists
09/26/2013US20130252958 Quinoline compound composing 1,2,4-triazine-dione and use thereof
09/26/2013US20130252957 Pyridinone antagonists of alpha-4 integrins
09/26/2013US20130252955 (aza)indole derivative and use thereof for medical purposes
09/26/2013US20130252946 Fluoroquinolone Carboxylic Acid Molecular Crystals
09/26/2013US20130252940 c-Met Modulators and Method of Use
09/26/2013US20130252934 Serine/threonine kinase inhibitors
09/25/2013EP2641901A1 Novel microbiocides
09/25/2013EP2640715A1 Quinoline derivatives as pik3 inhibitors
09/25/2013EP2640709A2 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
09/25/2013EP2640705A2 Novel antiviral compounds
09/25/2013EP2640704A1 Nampt inhibitors
09/25/2013EP2640703A1 Heterocyclic compounds as imaging probes of tau pathology
09/25/2013EP2640701A2 Cyanoenamines and their use as fungicides
09/25/2013EP2640467A1 Crystalline form of an inhibitor of mdm2/4 and p53 interaction
09/25/2013EP2640387A1 Method of treatment with braf inhibitor
09/25/2013EP2640189A1 3-deutero-pomalidomide
09/25/2013CN203207045U Novel device for producing special insecticide for ligustrun lucidum
09/25/2013CN103328452A Metalloenzyme inhibitor compounds
09/25/2013CN103328451A Compounds for the reduction of beta-amyloid production
09/25/2013CN103328449A Novel tetrahydroquinoline derivatives
09/25/2013CN103328446A Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer
09/25/2013CN103319468A Substituted spirobicyclic compounds, and application method and applications thereof
09/25/2013CN103319464A 病毒聚合酶抑制剂 Viral polymerase inhibitors
09/25/2013CN103319459A Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
09/25/2013CN103319458A Novel gamma-polymorph of Azelnidipine and applications thereof
09/25/2013CN103319457A Preparation method of novel gamma-polymorph of Azelnidipine
09/25/2013CN103319456A Dihydropyridine compounds, and compositions, preparation methods and applications thereof
09/25/2013CN103319408A Compounds for preventing and treating cardiovascular diseases
09/25/2013CN103319404A Nitroxoline derivatives and use of the nitroxoline derivatives as angiogenesis inhibitors
09/25/2013CN102775383B Organic compound for controlling plant viruses and application thereof
09/25/2013CN102432595B N-indole-1-amides compounds and application of N-indole-1-amides compounds as anti-cancer drugs
09/25/2013CN102108077B Method for preparing dexlansoprazole
09/25/2013CN101711242B ((Bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists
09/25/2013CN101679283B Process for preparing 2-amino-5-cyanobenzoic acid derivatives
09/24/2013US8541587 Lysophosphatidic acid receptor antagonists
09/24/2013US8541585 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
09/24/2013US8541580 Process for the preparation of pyrazinone thrombin inhibitor and its intermediates
09/24/2013US8541579 Substituted diketopiperazines as oxytocin antagonists
09/24/2013US8541573 Substituted sulfonamide compounds
09/24/2013US8541455 Derivatives of 2-pyridin-2-yl-pyrazol-3(2H)-one, preparation and therapeutic use thereof as HIF activators
09/24/2013US8541450 Process for the preparation of chiral 8-(3-aminopiperidin-1yl)-xanthines
09/24/2013US8541442 Indole derivatives as anticancer agents
09/24/2013US8541419 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as CRTH2 antagonists
09/24/2013US8541410 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
09/24/2013US8541404 Inhibitors of the human aldosterone synthase CYP11B2
09/24/2013US8541402 Viral polymerase inhibitors
09/24/2013US8541113 Pyrene compounds and organic electroluminescent devices using the same
09/24/2013US8540966 Contrast agents endowed with high relaxivity
09/24/2013CA2737739C Heteroaryl antagonists of prostaglandin d2 receptors
09/24/2013CA2722028C 5-hydroxypyrimidine-4-carboxamide compound
09/24/2013CA2667210C 1,5-diphenyl-3-pyridinylmethylamino-1,5-dihydropyrrolidin-2-one as a cb-1 receptor modulator
09/24/2013CA2653753C Substituted prolinamides, production thereof and their use as medicaments
09/24/2013CA2640652C Novel coumarin derivative having antitumor activity
09/24/2013CA2608184C N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
09/24/2013CA2592345C Piperidine and azetidine derivatives as glyt1 inhibitors
09/24/2013CA2591321C Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
09/24/2013CA2568914C Therapeutic agents, and methods of making and using the same
09/24/2013CA2562235C Piperazinylpiperidine derivatives as chemokine receptor antagonists
09/24/2013CA2560387C Cytokine inhibitors
09/24/2013CA2557645C Caspase inhibitors and uses thereof
09/24/2013CA2545425C Azole-based kinase inhibitors
09/24/2013CA2474277C 2,4-pyrimidinediamine compounds and their uses
09/19/2013WO2013138617A1 3,5-diaminopyrazole kinase inhibitors
09/19/2013WO2013138613A1 3,5-diaminopyrazole kinase inhibitors
09/19/2013WO2013137456A1 Antivirus composition
09/19/2013WO2013137234A1 Transparent electrode, electronic device, and method for producing transparent electrode
09/19/2013WO2013136141A1 An improved process for the preparation of alpha form of imatinib mesylate
09/19/2013WO2013136073A1 Agricultural chemicals
09/19/2013WO2013135724A1 Pesticidal arylpyrrolidines
09/19/2013WO2013135672A1 Fungicidal pyrimidine compounds
09/19/2013WO2013135671A1 Fungicidal pyrimidine compounds
09/19/2013WO2013135176A1 Aminoquinazoline derivative and use thereof in preparing anti-malignant tumor medicament
09/19/2013WO2013102929A4 Novel compounds for treatment of diabetes, obesity or related disorders
09/19/2013US20130245274 Process for the preparation of 3-(6-amino-pyridin-3yl)-2-acrylic acid derivatives
09/19/2013US20130245258 Preparation Method of alpha-imatinib Mesylate
09/19/2013US20130245256 Quinazoline analogs as receptor tyrosine kinase inhibitors
09/19/2013US20130245067 Deuterium-enriched lenalidomide
09/19/2013US20130245064 Novel neurotrypsin inhibitors
09/19/2013US20130245063 Compounds that modulate intracellular calcium
09/19/2013US20130245052 Novel polymorph of nilotinib hydrochloride
09/19/2013US20130245041 Dual-acting pyrazole antihypertensive agents
09/19/2013US20130245038 Method For Selecting Or Identifying A Subject For V1B Antagonist Therapy
09/19/2013US20130245036 Crystalline form of an inhibitor of mdm2/4 and p53 interaction
09/19/2013US20130245034 Inhibitors Of Histone Deacetylase
09/19/2013US20130245033 Amide compounds
09/19/2013US20130245016 Indoles
09/19/2013US20130245015 Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
09/19/2013US20130245005 Quinolin-4 (1h) -one derivatives as inhibitors of phosphatidylinositol 3-kinases
09/19/2013US20130245003 Carboxamide compounds and their use as calpain inhibitors
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 1080